Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

Artemisinin (Sweet Wormwood Cleanse)(Artemisia Annua) 200mg Per Serving, 120 Capsules (Two Month Supply) Vegan Safe, Non-GMO, Gluten Free, Manufactured in The USA (Immune Support) by Double Wood : Health & Household

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

Medsafe blocks sales of COVID-19 'treatment' Artemisia annua extract

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

Frontiers Prevalence of self-medication during COVID-19 pandemic: A systematic review and meta-analysis

The Global Science and Politics of Covid-19 / SARS-CoV-2

Covid 19 coronavirus: Medsafe blocks sales of 'treatment' Artemisia annua - NZ Herald

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

False advertising over Covid-19 cures targeted by Commerce Commission

Covid 19 coronavirus: Medsafe blocks sales of 'treatment' Artemisia annua - NZ Herald

Artemisia annua to be tested against COVID-19 Max Planck Institute of Colloids and Interfaces

Monica Tsacheff on LinkedIn: Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition